C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2011
12/06/2011	US8071536 Mutant DNA polymerases with improved pyrophosphorolysis activated polymerization (PAP) ability
12/06/2011	CA2519839C Flat, low pourer-closure with laminate or foil break-off element for composite packs or container openings, which are closed with a thick foil
12/06/2011	CA2518548C Peptide fragment of lyve-1 and antibody against the same
12/06/2011	CA2333306C Peptides based on the sequence of human lactoferrin and their use
12/06/2011	CA2305683C Immunogenic peptides from the hpv e7 protein
12/06/2011	CA2202087C Cloning and characterizing of genes associated with long-term memory
12/04/2011	CA2799391A1 Improved process for a folate-targeted agent
12/01/2011	WO2011150022A2 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof
12/01/2011	WO2011149909A2 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
12/01/2011	WO2011149310A2 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
12/01/2011	WO2011148959A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
12/01/2011	WO2011148952A1 Iga-binding peptide and iga purification using same
12/01/2011	WO2011148384A1 Novel process for the preparation of leuprolide and its pharmaceutically acceptable salts thereof
12/01/2011	WO2011148083A1 Peptide for use as a medicament, in particular for the treatment of cancer
12/01/2011	WO2011146972A1 Methods for the synthesis of dicarba bridges in peptides
12/01/2011	WO2011016043A3 Antibiotic drug delivery and potentiation
12/01/2011	US20110294748 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	US20110294743 Metastasis-specific peptides and their diagnostic and therapeutic applications
12/01/2011	US20110294740 Treatment of amyloidoses using myelin basic protein and fragments thereof
12/01/2011	US20110294738 Pthr1 receptor compounds
12/01/2011	US20110294728 Antiviral Polypeptides
12/01/2011	US20110294724 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
12/01/2011	US20110294723 Compounds
12/01/2011	US20110294722 Antimicrobial peptides
12/01/2011	US20110294721 Antimicrobial peptides
12/01/2011	US20110294226 Survival motor Neurons (SMN) gene: a gene for spinal muscular atrophy
12/01/2011	US20110294212 Methods of Screening Molecular Libraries and Active Molecules Identified Thereby
12/01/2011	US20110293728 Photosensitizer-metal nanoparticle complex and composition containing the complex for photodynamic therapy or diagnosis
12/01/2011	US20110293684 Surface-coated structures and methods
12/01/2011	US20110293646 PAN-DR Binding Polypeptides and Uses Thereof
12/01/2011	US20110293645 Wdrpuh epitope peptides and vaccines containing the same
12/01/2011	US20110293644 Compositions and methods for treatment of celiac disease
12/01/2011	US20110293641 A vaccinia virus protein a46 peptide and use thereof
12/01/2011	US20110293517 Nitrogen-Containing Macrocyclic Conjugates As Radiopharmaceuticals
12/01/2011	DE102010017130A1 Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung Hybrid compound, use thereof and process for their preparation
12/01/2011	CA2828605A1 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof
12/01/2011	CA2800535A1 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
12/01/2011	CA2799572A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
11/2011
11/30/2011	EP2389952A1 Lactadherin-derived peptides as antiviral agents
11/30/2011	EP2229408B1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
11/30/2011	CN102264756A 含rgd的拟肽和其用途 Rgd containing peptidomimetic and their uses
11/30/2011	CN102264755A 靶向vegfr-1/nrp-1的肽 Targeting vegfr-1 / nrp-1 peptide
11/30/2011	CN102260327A 一种美拉诺坦Ⅱ的制备方法 Melanotan Ⅱ a beauty preparation
11/30/2011	CN102260326A 卡贝缩宫素的制备方法 Carbetocin preparation
11/30/2011	CN102260325A Antibacterial peptide NX-16, and preparation method and application thereof
11/30/2011	CN102260324A 一种炎症前期趋化因子拮抗肽及其制备方法和应用 An inflammatory chemokine antagonistic pre-peptide and its preparation method and application
11/30/2011	CN102260323A 固相液相结合制备比伐卢定的方法和检测方法 Bivalirudin methods and detection methods combined with solid-phase liquid preparation
11/30/2011	CN102260322A 幽门螺杆菌抗原肽及其应用 Helicobacter pylori antigen peptide and its application
11/30/2011	CN102260321A 抗菌肽的多聚体形式 Multimeric form of antimicrobial peptides
11/30/2011	CN102260320A 具有抗肿瘤活性的化合物及其制备方法 Has the compounds and methods of anti-tumor activity
11/30/2011	CN102260319A 一种新型铂配合物、制备方法及用途 A new platinum complexes, preparation and use
11/30/2011	CN101638431B 能与NKp80 受体结合的多肽及其应用 With NKp80 receptor binding polypeptides and their Applications
11/30/2011	CN101580537B 一种人巨细胞病毒ul49基因抗原肽、及其抗体与应用 A human cytomegalovirus gene ul49 antigen peptide, and antibody and application
11/30/2011	CN101215323B 人ad7c-ntp抗原决定簇多肽、抗体及其在诊断试剂盒上的应用 People ad7c-ntp epitope peptides, antibodies and their use in the diagnosis kit
11/29/2011	US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium
11/29/2011	US8067534 Carbon nanotube binding peptides
11/29/2011	US8067533 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/29/2011	US8067379 Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
11/29/2011	US8067377 Peptide compositions for targeting adipose tissue
11/29/2011	US8067373 Therapeutic fibrin-derived peptides and uses thereof
11/29/2011	US8067363 Compositions and methods for promoting lipid mobilization in humans
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8066980 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same
11/29/2011	CA2442909C Multimerization of hiv-1 vif protein as a therapeutic target
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2233447C Mimicking peptides in cancer therapy
11/24/2011	WO2011145077A2 Branched polypeptides and their use in promoting adhesion of cells to solid surfaces
11/24/2011	WO2011145055A1 Novel cyclodecapeptide compounds for use as drugs
11/24/2011	WO2011144756A1 Biosynthetic proline/alanine random coil polypeptides and their uses
11/24/2011	WO2011144714A1 Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldt- jakob disease or diabetes mellitus
11/24/2011	WO2011094430A3 Pro-angiogenic fragments of prominin-1 and uses thereof
11/24/2011	US20110288271 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
11/24/2011	US20110288270 Comparative ligand mapping from mhc class i positive cells
11/24/2011	US20110288252 Dialkoxy- or dihydroxyphenyl radicals containing silanes, adhesives produced therefrom and method for producing silanes and adhesives
11/24/2011	US20110288235 Process for the Preparation of Pramlintide
11/24/2011	US20110288030 Paralytic Peptide for Use in Neuromuscular Therapy
11/24/2011	US20110288017 Apo-lipoprotein propeptide
11/24/2011	US20110288006 Peptides and methods for inducing cell death
11/24/2011	US20110287406 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
11/24/2011	US20110287041 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
11/24/2011	US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011	US20110286934 Membrane transduction peptides, polynucleotides, and methods
11/24/2011	US20110286929 Multivalent constructs for therapeutic and diagnostic applications
11/24/2011	US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
11/24/2011	CA2794614A1 Biosynthetic proline/alanine random coil polypeptides and their uses
11/23/2011	EP2388012A1 Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus
11/23/2011	EP2387580A1 Deoxyactagardine derivatives
11/23/2011	EP2387579A1 Polypeptides for specific targeting to otx2 target cells
11/23/2011	EP2387421A1 Compounds comprising n-formyl-methionine residues and tumor-targeting peptides
11/23/2011	EP1979375B1 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
11/23/2011	EP1511772B1 Method for obtaining anti-idiotype antibodies
11/23/2011	CN1832960B Immunomodulating compositions, uses therefor and processes for their production
11/23/2011	CN102257138A Tumor antigen peptide and use thereof
11/23/2011	CN102256994A Anticancer compounds
11/23/2011	CN102250220A Preparation method of colistin sulphate
11/23/2011	CN102250219A Method for preparing colistine sulfate B
11/23/2011	CN102250218A Method for hydrogen-bonding adsorption purification of oxytocin by using agarose comprising beta-cyclodextrin ligand
11/23/2011	CN102250217A Hyla simplex skin injury repair promotion polypeptides and genes as well as application thereof
11/23/2011	CN102250216A Rana nigromaculata antimicrobial peptide as well as gene and application thereof
11/23/2011	CN102250215A Wheat antioxidant peptide and preparation method thereof

1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 423